Gotzmann, M.; Henk, P.; Stervbo, U.; Blázquez-Navarro, A.; Mügge, A.; Babel, N.; Westhoff, T.H.
Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure. J. Clin. Med. 2023, 12, 4458.
https://doi.org/10.3390/jcm12134458
AMA Style
Gotzmann M, Henk P, Stervbo U, Blázquez-Navarro A, Mügge A, Babel N, Westhoff TH.
Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure. Journal of Clinical Medicine. 2023; 12(13):4458.
https://doi.org/10.3390/jcm12134458
Chicago/Turabian Style
Gotzmann, Michael, Pauline Henk, Ulrik Stervbo, Arturo Blázquez-Navarro, Andreas Mügge, Nina Babel, and Timm H. Westhoff.
2023. "Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure" Journal of Clinical Medicine 12, no. 13: 4458.
https://doi.org/10.3390/jcm12134458
APA Style
Gotzmann, M., Henk, P., Stervbo, U., Blázquez-Navarro, A., Mügge, A., Babel, N., & Westhoff, T. H.
(2023). Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure. Journal of Clinical Medicine, 12(13), 4458.
https://doi.org/10.3390/jcm12134458